Flecainide for the treatment of chronic neuropathic pain: a Phase II trial.

MLA

von Gunten CF, et al. “Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial.” Palliative Medicine, vol. 21, no. 8, Dec. 2007, pp. 667–72. EBSCOhost, https://doi.org/10.1177/0269216307083031.

APA

von Gunten CF, Eappen S, Cleary JF, Taylor SG 4th, Moots P, Regevik N, Cleeland C, & Cella D. (2007). Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliative Medicine, 21(8), 667–672. https://doi.org/10.1177/0269216307083031

Chicago

von Gunten CF, Eappen S, Cleary JF, Taylor SG 4th, Moots P, Regevik N, Cleeland C, and Cella D. 2007. “Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial.” Palliative Medicine 21 (8): 667–72. doi:10.1177/0269216307083031.